Skip to main content

American Oncology Network

corporate_fare Company Profile

American Oncology Network

AONC·OTC·Life Sciences·CIK 0001839998

American Oncology Network offers a physician-led, community-based oncology management model. The company supports community oncology practices by helping physicians navigate the healthcare landscape, providing an efficient platform for autonomous work, and improving patient care quality. American Oncology Network is an alliance of physicians and healthcare leaders focused on the long-term success of oncology diagnosis and treatment in community settings. As of December 31, 2024, American Oncology Network's platform includes 37 practices across 20 states and the District of Columbia, referred to as "Network Practices." This platform provides oncology practices with comprehensive support, access to revenue-diversifying adjacent services, and practice management expertise. The company aims to provide affordable cancer care close to where patients live and work, operating practices in both densely populated cities and rural areas with limited medical resources. American Oncology Network delivers cancer care innovation by introducing new treatments and ensuring access to necessary adjacent services for comprehensive quality cancer care, preserving personalized care in the community oncology setting. Patients at American Oncology Network clinics receive expert cancer care through services such as a centralized specialty pharmacy, clinical lab and pathology, a fully integrated technology platform with an oncology-specific electronic medical record system, a care management team, and various financial assistance programs.

American Oncology Network (OTC:AONC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for AONC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-10, rated 7/10.

Recent high-impact activity:

  • American Oncology Network Partners with Colla Health to Expand Behavioral Health Services

Financial Snapshot

Fiscal year ended December 31, 2024
Revenue
$1.76B
Net Income
-$26.96M
Diluted EPS
-$0.89
Op. Cash Flow
-$4.94M
Free Cash Flow
-$25.9M
Gross Profit
$117.85M
Operating Income
-$17.43M
Cash & Equivalents
$62.85M
Total Debt
$90.87M
Debt / Equity
-1.97×
Net Margin
-1.5%
Shares Outstanding
13.72M sh
Source: 10-K · filed 2025-03-27 · accession 0001628280-25-015237

Short Interest & Short Volume

29.92 days to cover

FINRA reported short interest of 8,498 shares in AONC as of the September 15, 2026 settlement, unchanged from the prior period — about 29.9 days to cover at its recent average daily volume. On September 30, 2026, 100.0% of AONC volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)8,498 shares as of September 15, 2026
Change vs prior period 0.0%
Days to cover29.92 at avg daily volume of 284
Daily short volume (FINRA facilities)100.0% of 100 shares on September 30, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

No longer listed

AONC (American Oncology Network) is no longer listed on a major US exchange, so Wiseek no longer shows market data for this symbol. It last appeared on NASDAQ. The filings and coverage below remain available as an archive.

feed AONC - Latest Insights

AONC
Jun 10, 2026, 9:04 AM EDT
Source: GlobeNewswire
Importance Score:
7
American Oncology Network Partners with Colla Health to Expand Behavioral Health Services
Sentiment: Positive
View Wiseek Article
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets